v3.26.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets    
Cash $ 846,656
Prepaid expenses 82,667
Short term prepaid insurance 105,000
Total current assets 1,034,323
Deferred offering costs 188,624
Long term prepaid insurance 81,008
Investments held in Trust Account 289,687,424
Total Assets 290,802,755 188,624
Current liabilities    
Accounts payable and accrued expenses 108,223
Accrued offering costs 75,000 86,328
Promissory note — related party   135,369
Total Current Liabilities 183,223 221,697
Deferred underwriting fee 10,062,500
Total Liabilities 10,245,723 221,697
Commitments and Contingencies (Note 6)
Class A ordinary shares subject to possible redemption, $0.0001 par value; 28,750,000 and no shares at redemption value of $10.08 and $0 per share as of March 31, 2026 and December 31, 2025, respectively 289,687,424
Shareholders’ Deficit    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding as of March 31, 2026 and December 31, 2025
Additional paid-in capital 24,042
Accumulated deficit (9,131,426) (58,073)
Total Shareholder’s Deficit (9,130,392) (33,073)
TOTAL LIABILITIES AND SHAREHOLDER’S DEFICIT 290,802,755 188,624
Related Party    
Current liabilities    
Promissory note — related party  
Class A Ordinary Shares    
Shareholders’ Deficit    
Ordinary shares, value 76
Class B Ordinary Shares    
Shareholders’ Deficit    
Ordinary shares, value [1] $ 958 $ 958
[1] As of December 31, 2025, includes an aggregate of up to 1,250,000 Class B ordinary shares that were subject to forfeiture by the holders thereof depending on the extent to which the underwriters’ over-allotment option was exercised (Note 5). On January 12, 2026, the Company consummated its Initial Public Offering and sold 28,750,000 Units, including 3,750,000 Units sold pursuant to the full exercise of the underwriters’ over-allotment option; hence, the 1,250,000 Class B ordinary shares are no longer subject to forfeiture.